Aytu BioPharma
(NASDAQ) AYTU
Aytu BioPharma Financials at a Glance
Market Cap
$23.29M
Revenue (TTM)
$56.60M
Net Income (TTM)
-$34.06M
EPS (TTM)
-$4.58
P/E Ratio
-0.47
Dividend
$0.00
Beta (Volatility)
0.91 (Low)
Dividend
$0.00
Beta (Volatility)
0.91 (Low)
Price
$2.18
Volume
140
Open
$2.18
Price
$2.18
Volume
140
Open
$2.18
Previous Close
$2.18
Daily Range
$2.18 - $2.18
52-Week Range
$1.65 - $3.07
Estimated Earnings Date
Sep 22, 2026
Dividend
$0.00
Beta (Volatility)
0.91 (Low)
Price
$2.18
Volume
140
Open
$2.18
Previous Close
$2.18
Daily Range
$2.18 - $2.18
52-Week Range
$1.65 - $3.07
Estimated Earnings Date
Sep 22, 2026
AYTU News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Aytu BioPharma
Industry
Pharmaceuticals
Sector
Health CareEmployees
83
CEO
Joshua R. Disbrow, MBA
Website
www.aytubio.comHeadquarters
Englewood, CO 80112, US
AYTU Financials
Key Financial Metrics (TTM)
Gross Margin
62.50%
Operating Margin
-26.79%
Net Income Margin
-60.17%
Return on Equity
-148.91%
Return on Capital
-18.68%
Return on Assets
-30.49%
Earnings Yield
-2.13%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$23.29M
Shares Outstanding
10.73M
Volume
140
Avg. Volume
40.43K
Financials (TTM)
Gross Profit
$35.38M
Operating Income
-$15.16M
EBITDA
-$27.33M
Operating Cash Flow
$1.68M
Capital Expenditure
-$34.00K
Free Cash Flow
$1.64M
Cash & ST Invst.
$26.72M
Total Debt
$22.94M
Aytu BioPharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$12.41M
-32.7%
Gross Profit
$6.84M
-46.6%
Gross Margin
55.10%
N/A
Market Cap
$23.29M
N/A
Market Cap/Employee
$228.34K
N/A
Employees
102
N/A
Net Income
-$5.62M
-240.7%
EBITDA
-$4.05M
-167.1%
Quarterly Fundamentals
Total Cash
$26.72M
+47.0%
Total Debt
$22.94M
+1.8%
Accounts Receivable
$24.49M
-31.6%
Inventory
$7.46M
-32.5%
Long Term Debt
$10.47M
-0.6%
Short Term Debt
$12.47M
+4.0%
Return on Assets
-30.49%
N/A
Return on Invested Capital
-29.32%
N/A
Free Cash Flow
-$4.18M
+35.9%
Operating Cash Flow
-$4.18M
+35.2%